These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 14720534)

  • 1. Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology.
    Patrono C; Bachmann F; Baigent C; Bode C; De Caterina R; Charbonnier B; Fitzgerald D; Hirsh J; Husted S; Kvasnicka J; Montalescot G; García Rodríguez LA; Verheugt F; Vermylen J; Wallentin L; Priori SG; Alonso Garcia MA; Blanc JJ; Budaj A; Cowie M; Dean V; Deckers J; Fernández Burgos E; Lekakis J; Lindahl B; Mazzotta G; Morais J; Oto A; Smiseth OA; Morais J; Deckers J; Ferreira R; Mazzotta G; Steg PG; Teixeira F; Wilcox R;
    Eur Heart J; 2004 Jan; 25(2):166-81. PubMed ID: 14720534
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiplatelet effect of aspirin in patients with coronary artery disease.
    Grove EL
    Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual Anticoagulant and Antiplatelet Therapy for Coronary Artery Disease and Peripheral Artery Disease Patients.
    Mackman N; Spronk HMH; Stouffer GA; Ten Cate H
    Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):726-732. PubMed ID: 29449336
    [No Abstract]   [Full Text] [Related]  

  • 4. Platelets and antiplatelet therapy in patients with diabetes mellitus.
    Arjomand H; Roukoz B; Surabhi SK; Cohen M
    J Invasive Cardiol; 2003 May; 15(5):264-9. PubMed ID: 12730635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chinese Society of Cardiology and Chinese College of Cardiovascular Physicians Expert Consensus statement on dual antiplatelet therapy in patients with coronary artery disease].
    ; ; ; ;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2021 May; 49(5):432-454. PubMed ID: 34034377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet agents for the treatment and prevention of atherothrombosis.
    Patrono C; Andreotti F; Arnesen H; Badimon L; Baigent C; Collet JP; De Caterina R; Gulba D; Huber K; Husted S; Kristensen SD; Morais J; Neumann FJ; Rasmussen LH; Siegbahn A; Steg PG; Storey RF; Van de Werf F; Verheugt F
    Eur Heart J; 2011 Dec; 32(23):2922-32. PubMed ID: 22019823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peri-operative management of antiplatelet therapy in patients with coronary artery disease: joint position paper by members of the working group on Perioperative Haemostasis of the Society on Thrombosis and Haemostasis Research (GTH), the working group on Perioperative Coagulation of the Austrian Society for Anesthesiology, Resuscitation and Intensive Care (ÖGARI) and the Working Group Thrombosis of the European Society for Cardiology (ESC).
    Korte W; Cattaneo M; Chassot PG; Eichinger S; von Heymann C; Hofmann N; Rickli H; Spannagl M; Ziegler B; Verheugt F; Huber K
    Thromb Haemost; 2011 May; 105(5):743-9. PubMed ID: 21437351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Antiplatelet Therapy in Coronary Disease.
    Falcão Gonçalves P; Menezes Falcão L
    Am J Ther; 2017; 24(6):e744-e750. PubMed ID: 26752652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pursuit of clinically relevant measures of platelet function after antiplatelet drug therapy.
    Cairns JA; Eikelboom J
    J Am Coll Cardiol; 2008 Dec; 52(24):1978-80. PubMed ID: 19055988
    [No Abstract]   [Full Text] [Related]  

  • 10. Platelets and Antiplatelet Therapy in Patients with Coronary Artery Disease and Diabetes.
    Neergaard-Petersen S; Hvas AM; Kristensen SD; Grove EL
    Semin Thromb Hemost; 2016 Apr; 42(3):234-41. PubMed ID: 26886397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease.
    Grove EL; Hvas AM; Mortensen SB; Larsen SB; Kristensen SD
    J Thromb Haemost; 2011 Jan; 9(1):185-91. PubMed ID: 20955349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-vessel wall interactions and drug effects.
    Twarock S; Bagheri S; Bagheri S; Hohlfeld T
    Pharmacol Ther; 2016 Nov; 167():74-84. PubMed ID: 27492900
    [No Abstract]   [Full Text] [Related]  

  • 13. Vorapaxar: emerging evidence and clinical questions in a new era of PAR-1 inhibition.
    Ungar L; Rodriguez F; Mahaffey KW
    Coron Artery Dis; 2016 Nov; 27(7):604-15. PubMed ID: 27398626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelets, inflammation and anti-inflammatory effects of antiplatelet drugs in ACS and CAD.
    Müller KA; Chatterjee M; Rath D; Geisler T
    Thromb Haemost; 2015 Aug; 114(3):498-518. PubMed ID: 26224127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
    Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
    Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.
    Abraham NS; Hlatky MA; Antman EM; Bhatt DL; Bjorkman DJ; Clark CB; Furberg CD; Johnson DA; Kahi CJ; Laine L; Mahaffey KW; Quigley EM; Scheiman J; Sperling LS; Tomaselli GF;
    J Am Coll Cardiol; 2010 Dec; 56(24):2051-66. PubMed ID: 21126648
    [No Abstract]   [Full Text] [Related]  

  • 17. Reduced antiplatelet effect of aspirin during 24 hours in patients with coronary artery disease and type 2 diabetes.
    Christensen KH; Grove EL; Würtz M; Kristensen SD; Hvas AM
    Platelets; 2015; 26(3):230-5. PubMed ID: 24750015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy.
    Cesari F; Marcucci R; Caporale R; Paniccia R; Romano E; Gensini GF; Abbate R; Gori AM
    Thromb Haemost; 2008 May; 99(5):930-5. PubMed ID: 18449424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of bleeding with the use of antiplatelet agents for the treatment of cardiovascular disease.
    Nathan AS; Sen S; Yeh RW
    Expert Opin Drug Saf; 2017 May; 16(5):561-572. PubMed ID: 28387542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease.
    Verdoia M; Pergolini P; Rolla R; Nardin M; Schaffer A; Barbieri L; Daffara V; Marino P; Bellomo G; Suryapranata H; De Luca G;
    Thromb Res; 2017 Feb; 150():90-95. PubMed ID: 28068529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.